Harm Vitzthum

Harm Vitzthum is an accomplished leader in the biotechnology and laboratory diagnostics sector with extensive experience in sales, business development, and scientific liaison roles across various organizations. Currently serving as the Director of Key Accounts EMEA at Agena Bioscience since July 2022, Harm Vitzthum focuses on expanding the customer base and developing customized DNA multiplex assays. Previous roles include Director of Customer Engagement and Scientific Liaison and Regional Director at Abbott, where responsibilities included liaising with key opinion leaders and managing a large team. Harm Vitzthum also held significant positions at Sysmex Europe, Beckman Coulter, Olympus Europa SE & Co. KG, Bayer, and Nichols Institute Diagnostics, demonstrating a strong track record in P&L responsibility, strategic account management, and market growth. Educational qualifications include a PhD in Neurobiology from the University of Regensburg.